New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 5, 2014
09:29 EDTNWBONorthwest CEO gave 'conflicting language' on timeline, Feuerstein says
The CEO of Northwest Biotherapeutics, Linda Powers, offered "conflicting language" yesterday regarding the timeline for enrollment of 312 glioblastoma patients in the phase III study of the experimental cancer vaccine DC-Vax, The Street's Adam Feuerstein writes. Reference Link
News For NWBO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 27, 2015
09:02 EDTNWBONorthwest Biotherapeutics reports survival data in patients treated with DCVAX-L
Subscribe for More Information
March 16, 2015
17:28 EDTNWBONorthwest Biotherapeutics files to delay Form 10-K
The company requires additional time to complete its year end procedures. Those procedures could not be completed without incurring undue hardship and expense. The company undertakes the responsibility to file such annual report no later than fifteen days after its original date.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use